Ilia I. Ouspenski

Array ( [id] => 5271011 [patent_doc_number] => 20090074787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 11/817395 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27644 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074787.pdf [firstpage_image] =>[orig_patent_app_number] => 11817395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106549 [patent_doc_number] => 20070065426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Tumor necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/365057 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13407 [patent_no_of_claims] => 138 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065426.pdf [firstpage_image] =>[orig_patent_app_number] => 11365057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789647 [patent_doc_number] => 20060206947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Heterodimeric protein binding compositions' [patent_app_type] => utility [patent_app_number] => 11/361528 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19989 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20060206947.pdf [firstpage_image] =>[orig_patent_app_number] => 11361528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602248 [patent_doc_number] => 20060292593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Dendritic cell co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 11/361057 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29941 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292593.pdf [firstpage_image] =>[orig_patent_app_number] => 11361057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292490 [patent_doc_number] => 07544782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/362327 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 41 [patent_no_of_words] => 14575 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544782.pdf [firstpage_image] =>[orig_patent_app_number] => 11362327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655217 [patent_doc_number] => 20060140952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/360446 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13408 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140952.pdf [firstpage_image] =>[orig_patent_app_number] => 11360446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445357 [patent_doc_number] => 07863419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Antibodies having altered effector function and methods for making the same' [patent_app_type] => utility [patent_app_number] => 11/360938 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17470 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863419.pdf [firstpage_image] =>[orig_patent_app_number] => 11360938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655216 [patent_doc_number] => 20060140951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/360136 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13412 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140951.pdf [firstpage_image] =>[orig_patent_app_number] => 11360136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655209 [patent_doc_number] => 20060140944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Novel polypeptides involved in immune response' [patent_app_type] => utility [patent_app_number] => 11/359254 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 31292 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140944.pdf [firstpage_image] =>[orig_patent_app_number] => 11359254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040222 [patent_doc_number] => 20070092504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses' [patent_app_type] => utility [patent_app_number] => 11/357434 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 54194 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092504.pdf [firstpage_image] =>[orig_patent_app_number] => 11357434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655202 [patent_doc_number] => 20060140937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'B7-related nucleic acids and polypeptides useful for immunomodulation' [patent_app_type] => utility [patent_app_number] => 11/355735 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 43582 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140937.pdf [firstpage_image] =>[orig_patent_app_number] => 11355735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264897 [patent_doc_number] => 20090117582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Diagnosis of Allergic Complaints, Atopic Diseases and/or Auto-Immune Diseases by the Identification of Antibodies Against CD28 in Human Serum' [patent_app_type] => utility [patent_app_number] => 11/815734 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7385 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117582.pdf [firstpage_image] =>[orig_patent_app_number] => 11815734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 865168 [patent_doc_number] => 07368554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Polynucleotides encoding BSL2v1c2-Ig' [patent_app_type] => utility [patent_app_number] => 11/346468 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 62 [patent_no_of_words] => 76273 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368554.pdf [firstpage_image] =>[orig_patent_app_number] => 11346468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693694 [patent_doc_number] => 20060153841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'B7-4 polypeptides and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/340429 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40286 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153841.pdf [firstpage_image] =>[orig_patent_app_number] => 11340429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608050 [patent_doc_number] => 20060269566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Novel co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 11/332037 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 97656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269566.pdf [firstpage_image] =>[orig_patent_app_number] => 11332037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322730 [patent_doc_number] => 07517963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => utility [patent_app_number] => 11/326996 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 41 [patent_no_of_words] => 14810 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517963.pdf [firstpage_image] =>[orig_patent_app_number] => 11326996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228541 [patent_doc_number] => 07601353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Peptide-based passive immunization therapy for treatment of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/323123 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 18 [patent_no_of_words] => 9584 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601353.pdf [firstpage_image] =>[orig_patent_app_number] => 11323123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872972 [patent_doc_number] => 20060165706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Antibodies against CTLA4 and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/321444 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32567 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165706.pdf [firstpage_image] =>[orig_patent_app_number] => 11321444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 229000 [patent_doc_number] => 07601813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Anti-GL50 antibodies' [patent_app_type] => utility [patent_app_number] => 11/311754 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 75 [patent_no_of_words] => 52769 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601813.pdf [firstpage_image] =>[orig_patent_app_number] => 11311754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373719 [patent_doc_number] => 20090311280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'NOVEL TNF RECEPTOR REGULATORY DOMAIN' [patent_app_type] => utility [patent_app_number] => 11/721308 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30745 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311280.pdf [firstpage_image] =>[orig_patent_app_number] => 11721308 [rel_patent_id] =>[rel_patent_doc_number] =>)